Libbie DiMarco's profile photo

Libbie DiMarco

Articles

  • Apr 30, 2024 | jdsupra.com | Libbie DiMarco

    April 30, 2024 To embed, copy and paste the code into your website or blog: 2023 was an exciting year for Section 337 litigation at the ITC and 2024 is off to an equally interesting start. In this article, Libbie DiMarco reviews five of the most interesting recent developments in Section 337 litigation. Originally published in IP Litigator, March/April 2024, Volume 30, Number 2, pages 31–32.

  • Apr 24, 2024 | mondaq.com | Libbie DiMarco

    2023 was an exciting year for Section 337 litigation at the ITC and 2024 is off to an equally interesting start. In this article, Libbie DiMarco reviews five of the most interesting recent developments in Section 337 litigation. 1. February 2023: The Commission Appoints Judge Doris Hines as the Newest ALJ. One of the most delightful developments of 2023 was the appointment of Judge Doris Hines in February 2023 as the sixth ITC Administrative Law Judge (ALJ).

  • Feb 5, 2024 | jdsupra.com | Libbie DiMarco

    Join litigation shareholder Libbie DiMarco as she breaks down the latest developments for mitigating ITC remedial orders with effective litigation strategies ranging from product redesigns (and when to introduce them) to PTAB challenges (and how to leverage the FWDs). Check-in to open at 3:30pm at the National Union Building. Session to begin at 4:00pm on the second floor. Please join us for a happy hour reception featuring cocktails and hors d’oeuvres following the session.

  • Jan 4, 2024 | jdsupra.com | Libbie DiMarco |John Harmon |Jeffrey Hsi |Daniel Young

    What should in-house counsel be on the lookout for in 2024? As we begin a new year, our attorneys look ahead at intellectual property topics they expect will be trending in 2024. They cover areas including life sciences, litigation, post-grant proceedings, artificial intelligence, design patents, and trademarks. LIFE SCIENCES In 2023’s Amgen v. Sanofi case, the United States Supreme Court determined that several of Amgen’s patent claims to a class of antibodies were invalid for lack of enablement.

  • Jan 2, 2024 | jdsupra.com | Libbie DiMarco

    2023 was an exciting year for Section 337 litigation at the ITC, particularly in the final quarter of the year. As we ring in the new year, Wolf Greenfield Shareholder Libbie DiMarco examines five of the most noteworthy ITC developments from 2023. 1. The ITC Banned Apple Watch Importation and Sales (Inv. No. 337-TA-1276): In the rapidly evolving and newsworthy dispute between Masimo Corporation and Apple, Inc. (Certain Light-Based Physiological Measurement Devices and Components Thereof, Inv.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →